Berberine decreases PCSK9 expression in HepG2 cells.

Berberine may be a useful supplement to statin treatment due to its effects on PCSK9 mRNA and protein levels, and a combination of berberine and mevastatin increases LDLR mRNA andprotein levels, while suppressing the increase in PCSK 9 mRNA levels caused by mevastsatin alone.